​

Funding Round

Series A - MiroBio

Series A - MiroBio

Investment Firm

Overview

MiroBio is Harnessing the natural control mechanisms of the immune system.

Announced Date

Oct 07, 2019

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Oxford Science Enterprises

Oxford Science Enterprises

Oxford Science Enterprises is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorSR One
Participant InvestorOxford Science Enterprises
Participant InvestorAdvent Life Sciences

Round Details and Background

MiroBio raised $33176136 on 2019-10-07 in Series A

MiroBio is Harnessing the natural control mechanisms of the immune system.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 07, 2019
Series A - MiroBio
4-33.2M
Jun 29, 2022
Series B - MiroBio
7-97.0M

Recent Activity

There is no recent news or activity for this profile.